HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angelika Mühlebner Selected Research

Depressive Disorder (Melancholia)

1/2020Reduced expression of the glucocorticoid receptor in the hippocampus of patients with drug-resistant temporal lobe epilepsy and comorbid depression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Angelika Mühlebner Research Topics

Disease

21Tuberous Sclerosis (Bourneville's Disease)
11/2022 - 01/2016
17Epilepsy (Aura)
01/2022 - 11/2014
15Focal Cortical Dysplasia
06/2022 - 02/2012
13Seizures (Absence Seizure)
06/2022 - 11/2016
6Drug Resistant Epilepsy
01/2022 - 02/2012
5Astrocytoma (Pilocytic Astrocytoma)
11/2022 - 11/2017
5Inborn Genetic Diseases (Disease, Hereditary)
01/2022 - 11/2016
4Partial Epilepsies (Epilepsy, Partial)
06/2022 - 02/2012
3Temporal Lobe Epilepsy
10/2021 - 03/2016
3Hippocampal Sclerosis
10/2021 - 03/2016
3Inflammation (Inflammations)
10/2021 - 01/2016
3Malformations of Cortical Development
10/2021 - 11/2017
2Brain Neoplasms (Brain Tumor)
11/2022 - 11/2017
2Neuroinflammatory Diseases
06/2022 - 01/2019
2Autism Spectrum Disorder
01/2022 - 10/2020
2Intellectual Disability (Idiocy)
01/2022 - 01/2017
2Status Epilepticus (Complex Partial Status Epilepticus)
10/2021 - 01/2018
2Hamartoma
01/2020 - 01/2016
2Carcinogenesis
01/2020 - 06/2018
2Infantile Spasms (West Syndrome)
10/2019 - 01/2019
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2022
1Neoplasms (Cancer)
01/2022
1Neurologic Manifestations (Neurological Manifestations)
01/2022
1Vaccinia
01/2022
1Neurodevelopmental Disorders
10/2021
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
01/2021
1Cognitive Dysfunction
10/2020
1Neurocutaneous Syndromes (Phakomatoses)
01/2020
1Hydrocephalus (Hydrocephaly)
01/2020
1Depressive Disorder (Melancholia)
01/2020
1Hemimegalencephaly
01/2019
1Encephalitis (Encephalitis, Rasmussen)
01/2019
1Ganglioglioma
06/2018
1Glioma (Gliomas)
06/2018
1Glioblastoma (Glioblastoma Multiforme)
06/2018
1Vomiting
01/2018
1Ketosis
01/2018
1Autistic Disorder (Autism)
01/2017
1Nervous System Diseases (Neurological Disorders)
11/2016
1Gliosis
01/2016
1Myoclonic Epilepsies (Myoclonic Encephalopathy)
01/2015

Drug/Important Bio-Agent (IBA)

21trans-sodium crocetinate (crocetin)IBA
11/2022 - 01/2016
8Pharmaceutical PreparationsIBA
06/2022 - 02/2012
6TOR Serine-Threonine KinasesIBA
01/2022 - 01/2016
4Mechanistic Target of Rapamycin Complex 1IBA
10/2021 - 01/2016
4mitomycin C-dextranIBA
10/2021 - 01/2019
3Sirolimus (Rapamycin)FDA Link
11/2022 - 01/2017
3Anticonvulsants (Antiepileptic Drugs)IBA
11/2017 - 01/2015
2Complement System Proteins (Complement)IBA
01/2022 - 09/2019
2AntioxidantsIBA
10/2021 - 01/2019
2Proteins (Proteins, Gene)FDA Link
10/2020 - 01/2017
2Adrenocorticotropic Hormone (ACTH)FDA Link
10/2019 - 01/2019
1CytokinesIBA
06/2022
1ChloridesIBA
06/2022
1Reticulin (Reticular Fiber)IBA
01/2022
1EverolimusFDA Link
01/2022
1MTOR InhibitorsIBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1Cell Adhesion MoleculesIBA
01/2022
1polycaprolactoneIBA
10/2021
1IronIBA
10/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Matrix Metalloproteinases (MMPs)IBA
01/2020
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2020
1MicroRNAs (MicroRNA)IBA
06/2018
13-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA
01/2018
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2017
1AMPA Receptors (AMPA Receptor)IBA
11/2016

Therapy/Procedure

3Therapeutics
10/2021 - 02/2012
3Ketogenic Diet
10/2019 - 01/2015
1Enteral Nutrition (Feeding, Tube)
01/2018
1Parenteral Nutrition
01/2018